Anastrozole provides a significant benefit compared with tamoxifen in preventing recurrence after a lumpectomy and radiation therapy in postmenopausal women ages 60 years or younger who had DCIS ...

To the Editor: Mehta et al. (Aug. 2 issue) 1 report that the combination of anastrozole and fulvestrant was superior to anastrozole alone when administered as first-line endocrine therapy to North ...

Anastrozole is a new generation nonsteroidal aromatase inhibitor, which selectively and potently blocks the enzymatic synthesis of estrogen from androgen. [1,2,3] ...

Sept. 23, 2003 (Copenhagen) — The risk of bone fracture associated with the use of anastrozole for treatment of early breast cancer in postmenopausal women appears to reach a plateau and does ...

Anastrozole, a breast cancer treatment drug, is now available to 289,000 women in England as a cancer preventative. Here, MailOnline answers your questions about the daily pill.

Study examines the efficacy of anastrozole in preventing breast cancer in postmenopausal women at high risk, focusing on the role of baseline estradiol levels and their impact on treatment outcomes.

Anastrozole is a drug used to both treat and prevent hormone-driven breast cancers. It works by reducing the amount of estrogen the body can make by blocking an enzyme called aromatase.

An oral medicine called anastrozole has been approved by the UK's drug regulatory agency for reducing the risk of breast cancer in post-menopausal women at moderate-to-high risk of the condition ...